Uncategorized Novartis AG (NVS) Strengthens Cardiovascular Unit with Tourmaline Bio Acquisition Post Content
Uncategorized Chime Launches New Credit Card with Cash Back Rewards, Updated Design to Attract, Retain Members Post Content
Uncategorized LifeSci Capital Reaffirms Buy Rating on Centessa Pharmaceuticals (CNTA) with a $39 PT, Anticipates Key Orexin Pipeline Data Post Content
Uncategorized Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT Post Content
Uncategorized BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic Dermatitis Post Content
Uncategorized Argus Lowers Cava Group (CAVA) PT to $76, Cites Realistic Calibration of Lowered Same-Store Sales Estimates Post Content